Brief: Ryvu Therapeutics Q3 Net Loss Widens To 18.3 Mln Zlotys
Nov 29 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q3 NET LOSS 18.3 MILLION ZLOTYS VERSUS LOSS OF 11.8
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING REVENUE 16.2 MILLION ZLOTYS VERSUS 19.7
MILLION
ZLOTYS YEAR AGO
* Q3 OPERATING LOSS 24.3 MILLION ZLOTYS VERSUS LOSS OF 12.9
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM6px8Ssa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys